Status:
UNKNOWN
Feasibility of Centralized Therapeutic Drug Monitoring of Fluoroquinolones in Multi-Drug Resistant Tuberculosis Patients
Lead Sponsor:
University Medical Center Groningen
Conditions:
Tuberculosis, Multidrug-Resistant
Eligibility:
All Genders
18+ years
Brief Summary
Observational, multi-centre, prospective study to investigate the feasibility of centralized TDM of moxifloxacin and levofloxacin in MDR-TB patients by determining turn-around time between sampling an...
Eligibility Criteria
Inclusion
- Pulmonary MDR-TB
- Sputum smear and sputum culture positive at baseline
- Oral administration of either moxifloxacin or levofloxacin
- Written informed consent (for use of the medical data)
Exclusion
- Pregnancy or breast feeding
Key Trial Info
Start Date :
February 10 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
360 Patients enrolled
Trial Details
Trial ID
NCT03409315
Start Date
February 10 2018
End Date
December 1 2020
Last Update
October 10 2019
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
The Prince Charles and Caboolture Hospitals
Brisbane, Australia
2
Republican Scientific and Practical Centre of Pulmonology and Tuberculosis
Minsk, Belarus
3
Hélio Fraga Reference Center
Rio de Janeiro, Brazil
4
Athens Chest Hospital "Sotiria"
Athens, Greece